AYAysun Yakut

Aysun Yakut

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aysun Yakut has a total of 382 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Physical Activity and Its Relationship with Patient Characteristics, Symptoms, Quality of Life, and Depression in Irritable Bowel Syndrome-A Cross-Sectional Study

    by Semiha Yenişehir, Aysun Yakut

    Aim: To investigate physical activity and its relationship with symptoms, quality of life (QoL), and depression in patients with Irritable Bowel Syndrome (IBS).Material and Methods: Eighty IBS patients (42 female, 38 male) were included. Subtypes of IBS, patient characteristics, symptoms (Gastrointestinal Symptom Rating Scale), QoL [Irritable Bowel Syndrome Quality of Life Scale (IBS-QoL)], depression (Beck Depression Scale), and physical activity (International Physical Activity Questionnaire (IPAQ)) were assessed. Abdominal pain severity was evaluated with visual analogue scale (VAS).Results: The demographic and clinical characteristics of the IBS subtypes (IBS-constipation [IBS-C]=36, IBS-diarrhea [IBS-D]=20, IBS-mixed [IBS-M]=24) were similar (p>0.05). The mean of abdominal pain VAS was 5.81±1.92. Most of the participants were minimally active (n=44, 55%) and inactive (n=29, 36.3%). IBS-M had worse interpersonal relationships (p=0.006) and was more depressed (p=0.020) than the IBS-C. Patient characteristics did not show a significant correlation with physical activity (p>0.05). Physical activity had a moderate correlation with symptoms (r=-0.508, p<0.001) and QoL (r=0.467, p<0.001), and had a weak correlation with depression (r=-0.284, p=0.001) in all participants. Physical activity had a moderate negative correlation with symptom severity (r=-0.421-(-0.596); p=0.011, p=0.006, p=0.009) and a positive moderate correlation with QoL (r=0.415-0.568; p=0.006, p=0.009, p=0.044), but no significant correlation with depression (p=0.106-0.357) in IBS-C, IBS-D, and IBS-M subtypes, respectively.Conclusion: IBS patients had low levels of physical activity. There were negative correlations between symptom severity and depression and physical activity levels, while QoL demonstrated a positive correlation in all participants.

  • Open Access

    Gastroenteroloji Textbook - Cilt (1-2)

    by Alper Macif, Ahmed Ramiz Baykan, Gökhan Çoban, Sadık Yavuz, Berk Bas, Mehmet Kasım Aydın, Selçuk Candan, Fatih Güzelbulut, Atilla Bulur, Fatih Ensaroğlu, et al.

  • Open Access

    Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis

    by Aysun Yakut

    The gut microbiota (GM) is a highly dynamic ecology whose density and composition can be influenced by a wide range of internal and external factors. Thus, “How do GM, which can have commensal, pathological, and mutualistic relationships with us, affect human health?” has become the most popular research issue in recent years. Numerous studies have demonstrated that the trillions of microorganisms that inhabit the human body can alter host physiology in a variety of systems, such as metabolism, immunology, cardiovascular health, and neurons. The GM may have a role in the development of a number of clinical disorders by producing bioactive peptides, including neurotransmitters, short-chain fatty acids, branched-chain amino acids, intestinal hormones, and secondary bile acid conversion. These bioactive peptides enter the portal circulatory system through the gut-liver axis and play a role in the development of chronic liver diseases, cirrhosis, and hepatic encephalopathy. This procedure is still unclear and quite complex. In this study, we aim to discuss the contribution of GM to the development of liver diseases, its effects on the progression of existing chronic liver disease, and to address the basic mechanisms of the intestinal microbiota-liver axis in the light of recent publications that may inspire the future.


  • Open Access

    Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway

    by Aysun Yakut

    I read the study by Zhao et al with great interest. Although the study design was quite complicated, it was successful in raising awareness of science and relevant researchers. Thirty patients with liver cirrhosis and portal hypertension secondary to chronic hepatitis B were included in the study. They were treated for variceal bleeding and underwent trans-jugular intrahepatic portosystemic shunt to prevent the recurrence of variceal bleeding and to reduce portal pressure. The authors evaluated the effects of changes in gut microbiota (GM) on hepatic encephalopathy secondary to portocaval bypass. The GM is greatly affected by local and general factors, including herbal and medical drugs, a person's dietary characteristics (carnivorous, vegan, vegetarian), supplementary foods, drinking water sources, and living in a city center or town. Therefore, I congratulate Zhao et al for their concise and comprehensive study on a multifactorial subject.


  • Open Access

    Retrospective cohort evaluation study in terms of cardiovascular and metabolic diseases in chronic hepatitis B patients

    by Aysun Yakut

    Background: Chronic hepatitis B (CHB) and nucleotide analogues [entecavir (ETV) and tenofovir disoproxil fumarate (TDF)] used in its treatment have been shown to affect metabolic parameters in many studies. In this study, we aimed to investigate the effects of metabolic events associated with CHB and nucleotide analogues (NAs) used in CHB treatment on ischemic heart diseases (IHD) and cardiovascular diseases (CVD).Methods: This retrospective study was conducted between June 2022 and January 2024 with a total of 241 patients diagnosed with non-cirrhotic CHB in the gastroenterology outpatient clinic, 96 of whom did not receive hepatitis B treatment, 110 of whom received TDF, and 35 of whom received ETV treatment. Patients were evaluated in terms of metabolic, CVD, and hepatology depending on whether they received antiviral treatment or not. In our study, the triglyceride-glucose (TyG) index and triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C) were calculated in patients to evaluate potential risk factors for CVD. Again, while the total cholesterol-to-HDL-C ratio (TC/HDL-C), which is associated with CVD\IHD, was evaluated, the ‘4-factor fibrosis index’ (FIB-4) score, which is a non-invasive indicator of liver fibrosis, was also evaluated.Results: Diabetes mellitus (DM), fasting blood sugar (FBS), oral antidiabetic drug (OAD) usage rate, and insulin usage rate were high in patients receiving ETV treatment. The TyG index of patients receiving ETV was higher than patients in the other group (p = 0.035; p<0.05). It was determined that the probability of detecting ETV treatment in patients with a TG/HDL-C ratio of ≥1.82 cut-off value was 4.250 times higher. The odds ratio for TG/HDL-C measurements was 4.250 (95% CI: 1.384–13.054). FIB-4 score, which is a non-invasive indicator of liver fibrosis, was found to be higher in patients receiving ETV than in other groups.Conclusion: In patients with CHB, a relationship was observed between markers used to predict CVD risk, such as the TyG index and TG/HDL-C ratio. The group with high levels of these two markers and a high potential for developing CVD was patients receiving ETV treatment. In this first study in the literature showing the relationship between CHB and CVD, we found that the relative risk of CVD was increased in patients using ETV.


  • Open Access

    İnflamatuvar Bağırsak Hastalığında Zorlu Hasta Grupları; Gebelik, Laktasyon, Fertilite

    by Aysun Yakut

    İnflamatuar bağırsak hastalığı (İBH) genç bireylerde yüksek bir insidans ve yaygınlığa sahiptir. İBH`da etkilenen hastalar sıklıkla üreme çağındaki popülasyon olması nedeni ile hastalar değerlendirilirken cinsellik, hastalığın kalıtımı, ilaçların ve hastalık aktivitesinin doğurganlık, gebelik sonuçları ve emzirme üzerindeki etkisinin de değerlendirilmesi gerekir. Puberte dönemindeki hastalarda hem hastalık aktivitesi hem de kullanılan ilaçlara bağlı (kortikosteroid gibi) pubertal gelişmede ve büyüme gelişiminde gecikmeler görebiliyoruz. Diğer taraftan İBH`lı hastaların çocuklarının sağlıkları hakkındaki belirsizlik, hastaların aile planlaması seçimlerini etkileyebilir. Bu nedenle, gebe kalmak isteyen veya gebe olan hastaların yönetimi, uzmanlaşmış danışmanlık ve uygun yönetim gerektirir. Bu, multidisipliner bir yaklaşım ve ortak bir karar alma modeli altında olası ebeveynlerin yakın katılımını içerir. Bu sorunları ele alarak pubertal gelişim, doğurganlık gebelik öncesi, gebelik ve gebelik sonrası İBH yönetimi ve danışmanlığını optimize etmeyi ve uyumlu hale getirmeyi amaçladık.

  • Open Access

    Polypectomy Technique and Histopathological Evaluation in Colon Polyps According to Paris Classification

    by Aysun Yakut, Şeyma Büyücek, Mehmet Özcan, Mustafa Nacir

    Objective: Colorectal cancers are in third place in terms of incidence and second in terms of mortality. This study aims to type the polyps detected during colonoscopy according to the Paris classification, perform polypectomy with the appropriate technique, classify them as histopathological, determine the presence of dysplasia, and review the risk status of colorectal cancer. Material and Method: Our study is a retrospective study presented as a one-year review of 124 patients who were found to have colonic polyps due to colonoscopy, who underwent polypectomy with the appropriate technique, and whose histopathological determination was completed. Results: The study was conducted between 2021 and 2022 with a total of 124 cases, 37.9% female and 62.1% male. The mean age of the cases was 58.58 ± 14.40 years. The way the polyps were removed was determined according to the polyp size and the Paris classification. Polypectomy was performed with biopsy forceps for

  • Open Access

    Contribution of Fecal Calprotectin and Fecal Immunochemical Tests to the Evaluation of Patients with Ulcerative Colitis

    by Aysun Yakut

    Cite this article as: Yakut A. Contribution of fecal calprotectin and fecal immunochemical tests to the evaluation of patients with ulcerative colitis. Turk J Gastroenterol. 2024;35(6):509-510.


  • The Comparison of Clinicopathological Features of Patients with Hiatal Hernia Detected Endoscopically

    by Aysun Yakut, Murat Aladag

    Amaç: Hiatal herni (HH); abdominal kompartmandaki mide gibi organ ve dokuların göğüs boşluğuna yerdeğiştirmesidir. HH özofagus ile diyafram arasındaki oryantasyona göre sınıflandırılır. Hastalar genellikle asemptomatik olup bazen gastrik reflü, mide bulantısı, şişkinlik, retrosternal ağrı, gastroözofagial kanama ve disfaji gibi birçok klinikle prezente olabilir. Bu çalışmada; HH olan hastaların, klinik prezentasyonunu değerlendirmek, endoskopik olarak tanısını sınıflandırarak koymak ve tedavide medikal ve invaziv olarak neler yapılabileceğini vurgulamak istedik. Gereç ve yöntemler: Bu çalışma 2021-2022 tarihleri arasında endoskopi ünitemize başvurmuş 565 hastanın gastroskopisinde HH tespit edildiği retrospektif bir çalışmadır. Gastroskopisinde HH`si olmayan ve kardia gevşekliği olan hastalar çalışmaya dahil edilmedi. Hastaların demografik özellikleri, şikayetleri, endoskopik bulguları, patolojik bulguları ve takipleri hastane veri tabanından kaydedildi. Bu veriler değerlendirilirken, istatistiksel analizler için NCSS (Number Cruncher Statistical System) 2020 Statistical Software (NCSS LLC, Kaysville, Utah, USA) programı kullanıldı. Bulgular: Çalışmamıza katılan 565 hastanın %40,2’sinin (n=227) kadın, %59,8’inin (n=338) erkekti. HH olanların yaşları 16 ile 103 arasında değişmekte olup, ortalama yaş 49,31±17,08 olarak belirlenmiştir. HH olan hastalarda sıklıkla Tip I sliding tipte HH tespit edilmiştir. Semptomatik hastalarda genellikle reflü şikayeti olup proton pompa inhibitörleri, anti-asitler, aljinat gibi ilaçlarla sıklıkla semptomatik iyileşme sağlandığı tespit edilmiştir. Sonuç: HH genellikle asemptomatik olmakla birlikte, semptomatik vakalarda ciddi klinik bir sorundur. Tip I sliding HH sıklıkla tespit edilir, bu hastalar genellikle yaşam tarzı değişikliği ve medikal tedavi ile semptomatik iyileşme sağlamaktadır. Ancak tedaviye dirençli ve komplike hastalarda endoskopik ve\veya cerrahi maniplasyonlar ile semptomatik iyileşme sağlanmaktadır.

  • Open Access

    The relationship between serum uric acid levels and liver stiffness in patients with type II diabetes mellitus and fatty liver disease

    by Aysun Yakut

    OBJECTIVE: High serum uric acid levels are associated with metabolic syndrome and diabetes mellitus. Several observational studies have shown the association between metabolic dysfunction-associated fatty liver disease and high serum uric acid. However, this association is controversial due to reverse causality. We aimed to investigate the relationship between the serum uric acid level and "aspartate aminotransferase-platelet ratio index score," which noninvasively shows the possible changes of metabolic dysfunction-associated fatty liver disease in the liver in patients diagnosed with type II diabetes mellitus.